Details for New Drug Application (NDA): 012486
✉ Email this page to a colleague
NDA 012486 describes TARACTAN, which is a drug marketed by Roche and is included in three NDAs. Additional details are available on the TARACTAN profile page.
The generic ingredient in TARACTAN is chlorprothixene. Additional details are available on the chlorprothixene profile page.
The generic ingredient in TARACTAN is chlorprothixene. Additional details are available on the chlorprothixene profile page.
Summary for 012486
| Tradename: | TARACTAN |
| Applicant: | Roche |
| Ingredient: | chlorprothixene |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 012486
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 100MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 50MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 004
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 25MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
